SAB Biotherapeutics : Reports Full Year 2023 Operating and F

SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results


March 29, 2024


SAB-142 Phase 1 trial on track for data release during 2024


...

Related Keywords

New York , United States , Michaelg King Jr , Andrew Moin , Erick Lucera , Samuelj Reich , Katie Ellias , Rd Fund , Exchange Commission , Twitter , Linkedin , Biotherapeutics Inc , Nasdaq , Young , Reports Full Year , Financial Results , Recent Corporate Developments , Chief Financial , Sessa Capital , New York City Chapter , Managing Partner , Veralox Therapeutics , Chief Financial Officer , Annual Needham Virtual Conference , Private Securities Litigation Reform Act , Markets ,